Status:
ACTIVE_NOT_RECRUITING
Voyage: Real-World Impact of the Multi-target Stool DNA Test on CRC Screening and Mortality
Lead Sponsor:
Exact Sciences Corporation
Collaborating Sponsors:
Mayo Clinic
Conditions:
Colon Cancer
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to gather information about the long term health of people who have been prescribed the Cologuard test, which is used for colorectal cancer (CRC) screening.
Detailed Description
Participates will be consented for prospective follow-up for health outcomes, which will be ascertained through periodic contacts. Participants will complete a baseline health questionnaire survey (T0...
Eligibility Criteria
Inclusion
- Resident of the United States
- Age 18 years or older
- Able to provide informed consent
- Able to complete surveys in English or Spanish
- Valid order for Cologuard screening
Exclusion
- N/A
Key Trial Info
Start Date :
October 18 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
150000 Patients enrolled
Trial Details
Trial ID
NCT04124406
Start Date
October 18 2019
End Date
December 1 2025
Last Update
October 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic
Rochester, Minnesota, United States, 55905